Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
A EARLY_PHASE1 clinical study on Motor Function of Healthy Physiology, this trial is completed. The trial is conducted by National Institute of Neurological Disorders and Stroke (NINDS) and has accumulated 70 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)Objectives Noninvasive stimulation of the central and peripheral nervous system, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS and tACS, respectively) and cutaneous/peripheral nerve stimulation (C/PNS) alone or paired with TMS (paired associative stimulation, PAS), has been increasingly used in the investigation of cortical plasticity and as a possible adjuvant strategy in neurorehabilitation. It has been shown that TMS, tDCS, tACS and C/PNS can modulate motor function in healthy volunteers, as well as in patients with neurological disorders such as stroke. One fundamental problem is that the optimal parameters of stimulation to modulate motor function by all of these techniques are not known. The purpose of this protocol has been to explore within safe guidelines, the effects of different stimulation parameters on motor cortical function, on oscillatory brain dynamics measured with magnetoencephalography (MEG) and electroencephalography (EEG), on eye movements, and on fMRI activation. In addition, this protocol was used to train new fellows coming to NINDS Human Cortical Physiology Section (HCPS) in the use of TMS, tDCS, tACS and C/PNS techniques. We expected that information emerging from these studies would allow us to 1) optimize experimental protocols or stimulation parameters to collect pilot data in healthy...
Objectives
Noninvasive stimulation of the central and peripheral nervous system, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS and tACS, respectively) and cutaneous/peripheral nerve stimulation (C/PNS) alone or paired with TMS (paired associative stimulation, PAS), has been increasingly used in the investigation of cortical plasticity and as a possible adjuvant strategy in neurorehabilitation. It has been shown that TMS, tDCS, tACS and C/PNS can modulate motor function in healthy volunteers, as well as in patients with neurological disorders such as stroke.
One fundamental problem is that the optimal parameters of stimulation to modulate motor function by all of these techniques are not known. The purpose of this protocol has been to explore within safe guidelines, the effects of different stimulation parameters on motor cortical function, on oscillatory brain dynamics measured with magnetoencephalography (MEG) and electroencephalography (EEG), on eye movements, and on fMRI activation. In addition, this protocol was used to train new fellows coming to NINDS Human Cortical Physiology Section (HCPS) in the use of TMS, tDCS, tACS and C/PNS techniques.
We expected that information emerging from these studies would allow us to 1) optimize experimental protocols or stimulation parameters to collect pilot data in healthy volunteers for future patient-oriented hypothesis-driven protocols, 2) to collect pilot data for power analysis for future patient-oriented hypothesis driven protocols, and 3) to train new fellows in the use of these different methods.
As instructed, we had stopped recruitment under this protocol at the time we were informed by the NIH IRB that they determined this to be a thematic protocol (August 6, 2019). The four specific aims addressed under this protocol are:
1. Aim 1. To identify resting behavioral and physiological substrates for neuromodulation of motor behavior 2. Aim 2. To identify task-dependent behavioral and physiological substrates for neuromodulation of motor behavior 3. Aim 3. To understand variability, rigor or/and reproducibility of brain stimulation effects.
As instructed, the purpose of this amendment is to request authorization to proceed with data analysis and publication. No new experiments will be carried out under this protocol.
Study Population
Up to 1500 healthy volunteers, age 18 and older.
Design
No new experiments will be carried out under this protocol. Previously, healthy volunteers received one or more of the following types of stimulation alone or in combination: (1) single- and paired-pulse TMS with inter-stimulus intervals of greater than 1s and up to 20s and intensities of up to 100% of stimulator output; (2) 1 Hz TMS for up to 30mins and up to 115% of resting motor threshold (RMT) intensity; (3) tDCS applied at an intensity of up to 4 mA for a duration of up to 60mins, as long the total charge does not exceed 7.2 C; (4) tACS applied at a peak-to-peak intensity of up to 4 mA for a duration of up to 60 minutes, as long the total charge does not exceed 7.2 C; (5) C/PNS applied alone with intensities below 130% of the peripherally-elicited-motor-threshold for up to 2 hours, or intensities up to 300% of sensory threshold when C/PNS is paired with TMS. All of these parameters of stimulation and procedures have safely been used as previously reported in the literature. Sham stimulations were delivered for each modality as scientifically needed. Some sessions included recording of behavior or brain activity (such as behavioral testing, MRI, and MEG) if brain stimulation targets were unknown. This information was used to inform the design of brain stimulation protocols.
Each subject was able to participate in up to one experimental session per day, and up to 20 total sessions over a twenty year period under this protocol. A single session lasted no longer than 8 hours. Appropriate rest breaks and meal breaks occured during long sessions. CTDB was used to track the number of sessions per subject to ensure they did not exceed 20 sessions. Protocol AIs were responsible for entering the subjects/sessions into CTDB.
We previously tested the effects of different forms of stimulation on motor cortical excitability, cognitive and motor behavioral tasks, and brain state measures derived from neuroimaging data (i.e. - MRI, fMRI, MEG and EEG). Stimulation was be applied before, after, or during physiological (i.e. motor evoked potentials, M-wave, F-wave, or H-Reflexes), neuroimaging or behavioral measures.
Outcome Measures
No new outcome measures are proposed. Changes in motor cortical excitability were previously measured as the change in the average peak-to-peak amplitude of a motor evoked potential (MEP) as measured with EMG. Neuroimaging measures included changes in oscillatory brain activity power as measured with EEG or MEG, changes in BOLD fMRI activation or changes in functional connectivity (i.e. covarying fluctuations in BOLD or spectral power across the brain). Behavioral outcome measures focused on changes in performance as a function of learning, or as a function of applied brain stimulation.
Status Flow
Change History
70 versions recorded-
Mar 2026 — Present [monthly]
Completed EARLY_PHASE1
-
Feb 2026 — Mar 2026 [monthly]
Completed EARLY_PHASE1
-
Feb 2026 — Present [monthly]
Completed EARLY_PHASE1
-
Jan 2026 — Present [monthly]
Completed EARLY_PHASE1
-
Dec 2025 — Feb 2026 [monthly]
Completed EARLY_PHASE1
▶ Show 65 earlier versions
-
Sep 2025 — Dec 2025 [monthly]
Completed EARLY_PHASE1
-
Aug 2025 — Sep 2025 [monthly]
Completed EARLY_PHASE1
-
Jul 2025 — Aug 2025 [monthly]
Completed EARLY_PHASE1
-
Jun 2025 — Jul 2025 [monthly]
Completed EARLY_PHASE1
-
May 2025 — Jun 2025 [monthly]
Completed EARLY_PHASE1
-
Apr 2025 — May 2025 [monthly]
Completed EARLY_PHASE1
-
Mar 2025 — Apr 2025 [monthly]
Completed EARLY_PHASE1
-
Jan 2025 — Mar 2025 [monthly]
Completed EARLY_PHASE1
-
Dec 2024 — Jan 2025 [monthly]
Completed EARLY_PHASE1
-
Nov 2024 — Dec 2024 [monthly]
Completed EARLY_PHASE1
-
Oct 2024 — Nov 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
May 2024 — Jun 2024 [monthly]
Completed EARLY_PHASE1
-
Apr 2024 — May 2024 [monthly]
Completed EARLY_PHASE1
-
Mar 2024 — Apr 2024 [monthly]
Completed EARLY_PHASE1
-
Feb 2024 — Mar 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2024 — Feb 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2023 — Jan 2024 [monthly]
Completed EARLY_PHASE1
-
Oct 2023 — Nov 2023 [monthly]
Completed EARLY_PHASE1
-
Sep 2023 — Oct 2023 [monthly]
Completed EARLY_PHASE1
-
Aug 2023 — Sep 2023 [monthly]
Completed EARLY_PHASE1
-
Jul 2023 — Aug 2023 [monthly]
Completed EARLY_PHASE1
-
Jun 2023 — Jul 2023 [monthly]
Completed EARLY_PHASE1
-
Apr 2023 — Jun 2023 [monthly]
Completed EARLY_PHASE1
-
Feb 2023 — Apr 2023 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Feb 2023 [monthly]
Completed EARLY_PHASE1
-
Sep 2022 — Dec 2022 [monthly]
Completed EARLY_PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Completed EARLY_PHASE1
-
Jun 2022 — Jul 2022 [monthly]
Completed EARLY_PHASE1
-
May 2022 — Jun 2022 [monthly]
Completed EARLY_PHASE1
-
Apr 2022 — May 2022 [monthly]
Completed EARLY_PHASE1
-
Mar 2022 — Apr 2022 [monthly]
Completed EARLY_PHASE1
-
Feb 2022 — Mar 2022 [monthly]
Completed EARLY_PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Completed EARLY_PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Completed EARLY_PHASE1
-
Nov 2021 — Dec 2021 [monthly]
Completed EARLY_PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Completed EARLY_PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Completed EARLY_PHASE1
-
Feb 2021 — Sep 2021 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Completed EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Oct 2020 — Nov 2020 [monthly]
Completed EARLY_PHASE1
-
Jul 2020 — Oct 2020 [monthly]
Completed EARLY_PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Completed EARLY_PHASE1
-
May 2020 — Jun 2020 [monthly]
Completed EARLY_PHASE1
-
Mar 2020 — May 2020 [monthly]
Completed EARLY_PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Completed EARLY_PHASE1
Phase: None → EARLY_PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
-
Aug 2019 — Dec 2019 [monthly]
Recruiting
-
May 2019 — Aug 2019 [monthly]
Recruiting
-
Mar 2019 — May 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .